| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.33B | 82.15B | 88.80B | 93.72B | 132.51B | 76.58B |
| Gross Profit | 3.63B | 8.43B | 11.54B | 13.47B | 26.92B | 14.85B |
| EBITDA | 12.16B | 14.43B | 18.02B | 17.57B | 28.14B | 18.95B |
| Net Income | 2.51B | 2.61B | 2.62B | 4.77B | 13.89B | 5.82B |
Balance Sheet | ||||||
| Total Assets | 147.71B | 139.20B | 150.08B | 146.37B | 156.35B | 143.60B |
| Cash, Cash Equivalents and Short-Term Investments | 14.78B | 15.09B | 14.98B | 16.98B | 18.41B | 14.55B |
| Total Debt | 36.57B | 39.20B | 41.84B | 39.14B | 36.87B | 38.13B |
| Total Liabilities | 93.42B | 91.41B | 99.43B | 97.80B | 106.12B | 104.08B |
| Stockholders Equity | 49.19B | 42.94B | 47.78B | 48.10B | 49.76B | 39.44B |
Cash Flow | ||||||
| Free Cash Flow | 3.00B | 4.63B | 5.09B | 6.38B | 9.76B | 7.91B |
| Operating Cash Flow | 12.38B | 13.33B | 13.09B | 15.12B | 17.46B | 12.86B |
| Investing Cash Flow | -9.97B | -8.59B | -9.23B | -9.38B | -6.93B | -12.02B |
| Financing Cash Flow | -2.54B | -4.30B | -5.97B | -5.65B | -8.63B | -2.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $134.36B | 3.80 | 27.02% | 14.10% | -2.43% | 171.38% | |
71 Outperform | $252.71B | 12.10 | 10.06% | 3.92% | -5.79% | 19.45% | |
66 Neutral | $101.71B | 12.11 | 3.44% | 7.43% | 3.95% | -38.27% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | $82.35B | 16.84 | 5.20% | 5.41% | -3.06% | 9.20% | |
59 Neutral | $122.76B | 1,640.39 | 5.52% | 5.62% | 4.29% | ― |